Byannli (previously Paliperidone Janssen-Cilag International)
Analogs of Byannli (previously Paliperidone Janssen-Cilag International)
Find cheaper analogs and generic equivalents for Byannli (previously Paliperidone Janssen-Cilag International).
Active Ingredient: paliperidone palmitate
Product Overview
About Byannli (previously Paliperidone Janssen-Cilag International)
Byannli is a prolonged-release suspension for injection in pre-filled syringes (700 and 1,000 mg).
What it is used for
Not available in the provided facts.
How it is used
Byannli is injected once every 6 months in the gluteal muscle (buttocks); the dose depends on the previous monthly or three-monthly dose. For more information about using Byannli, see the package leaflet or contact your doctor or pharmacist.
How it works
The active substance in Byannli, paliperidone, is an active breakdown product (metabolite) of risperidone, another antipsychotic medicine that has been used in the treatment of schizophrenia since the 1990s. In the brain, it attaches to several different receptors on nerve cells. This disrupts signals transmitted between brain cells by ‘neurotransmitters’, chemicals that allow nerve cells to communicate with each other. Paliperidone acts mainly by blocking receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin), which are involved in schizophrenia. By blocking these receptors, paliperidone helps to normalise the activity of the brain and reduce symptoms of the disease.
Active substance: paliperidone
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
